David Vs Goliath – Flarin’s Macmillen On Slugging It Out With The Heavyweights
Executive Summary
HBW Insight Exclusive: Flarin boss Andrew Macmillen on competing with the big OTC incumbents as a lean, innovation-focused company.
You may also be interested in...
EU Business Round-Up: Mayoly Spindler Acquires Biohealth, Flarin Gets Funding, Karo Ready For M&A
The latest European consumer health business news: France's Mayoly Spindler acquires Italian supplements specialist Biohealth; UK-based Flarin gets funding to expand at home and abroad; and Sweden's Karo plots further M&A in 2021.
Top 10 UK OTC Marketing Stories 2020: Digital Health And Probiotics Lead The Way
HBW Insight's countdown of the top-10 most read UK OTC marketing stories in 2020 includes launches and campaigns from consumer health players such as Sanofi, J&J, GSK and Bayer, amongst others.
‘Acquisitive and Entrepreneurial’ Stada Spies Further M&A Opportunities In US And Elsewhere
Stada Arzneimittel is looking for local partners and/or acquisition opportunities in the US to expand its offer and quickly establish its presence in the country, Stada executive vice president Roger Scarlett-Smith tells HBW Insight in this exclusive interview.